WHO Advisory Group of the Critically Important Antimicrobials for Human Medicine (AG-CIA)
WHO Advisory Group of the Critically Important Antimicrobials for Human Medicine (AG-CIA) supports the WHO Unit on Impact Initiatives and Research in the future revisions of the WHO List of Critically Important Antimicrobials (CIA).

The WHO List of Critically Important Antimicrobials (CIA)

Introduction

WHO CIA list categorizes all antimicrobials used in human medicine into 3 groups based on their importance to human medicine. The scope currently is limited to antibacterial drugs of which most are also used in veterinary medicine. The list assists in managing antimicrobial resistance, ensuring that all, especially critically important antimicrobials are used prudently both in human and veterinary medicine.

Latest WHO List of Critically Important Antibiotics (CIA)

20 March 2019

Critically important antimicrobials for human medicine : 6th revision
Ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use
Download
Read More

Other available languages

Infographics

The WHO Advisory Group of the Critically Important Antimicrobials for Human Medicine (AG-CIA)

Functions of the Advisory Group of the Critically Important Antimicrobials for Human Medicine

The mandate of the AG-CIA is:

  1. to provide independent scientific and technical advice for future revisions of the WHO CIA List;
  2. to review and analyze scientific information to update the ranking of antimicrobials based on the criteria established in the latest WHO CIA List;
  3. to advise on the approach to address the use of antimicrobials in different sectors (for example plants or crops) to be included in the next WHO CIA list;
  4. to review and provide technical advice and support on relevant publications; and
  5. to advise and support WHO in promoting the use of the WHO CIA List in countries for prioritization of risk management strategies in the human sector, the food animal sector, in agriculture (crops) and horticulture, through a coordinated multisectoral One Health approach.

More information can be found on the Terms of Reference of the AG-CIA.

WHO AG-CIA Group Chair

 

WHO AG-CIA Group Members

Professor Scott Weese

Chair

Professor Bruno Gonzalez-Zorn
Dr Catrin Moore
Dr David George White
Dr Gérard Moulin
Professor Iddya Karunasagar
Professor Hosam Mamoon Zowawi
Dr Andreas Palzer
Dr Liliana Ofelia Clara
Dr Mohammad Issack
Professor Motoyuki Sugai
Professor Olga Perovic
Professor Peter Collignon
Dr Ruby Singh
Professor Fatma Amer
Dr Kushlani Jayatilleke

Medical microbiologist, Sri Jayewardenepura Hospital, Sri Lanka

NOTE: The TAG members are participating in the meetings on their individual capacity. Affiliations are presented only as a reference. The participation of experts in a WHO meeting does not imply that they are endorsed or recommended by the WHO nor does it create a binding relationship between the experts and WHO. The biographies have been provided by the experts themselves and are the sole responsibility of the individuals concerned. WHO is not responsible for the accuracy, veracity and completeness of the information provided. In accordance with WHO conflict of interest assessment policy, expert’s biographies are published for transparency purposes. Comments and perceptions are brought to the knowledge of WHO through the public notice and comment process. Comments sent to WHO are treated confidentially and their receipt will be acknowledged through a generic email notification to the sender. Please send any comments to the following email: antibacterialpipeline@who.int. WHO reserves the right to discuss information received through this process with the relevant expert with no attribution to the provider of such information. Upon review and assessment of the information received through this process, WHO, in its sole discretion, may take appropriate management of conflicts of interests in accordance with its policies.